Study To Assess The Efficacy, Safety, And Tolerability Of Drug vs Placebo In Chronic Obstructive Pulmonary Disease
This is a study to evaluate the efficacy of an injection treatment compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD (Chronic Obstructive Pulmonary Disease).
Carolina Clinical Research is currently seeking study participants 40 to 85 years of age with a current COPD diagnosis of at least one year, with a smoking history of greater than or equal to 10 years, but who are not currently smoking.
This study is currently sponsored by Sanofi, in collaboration with Regeneron Pharmaceuticals.